Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner? (Q33718366)

28 July 2017

1 reference

title

Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner? (English)

1 reference

28 July 2017

2

Openshaw P

1 reference

28 July 2017

Hussell T

1

1 reference

28 July 2017

publication date

1 August 1999

1 reference

Current Opinion in Microbiology

28 July 2017

published in

1 reference

28 July 2017

volume

2

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

410-414

1 reference

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

T cell subset analysis in peripheral blood of children with RSV bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Maternal immunization against viral disease

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Protection against respiratory syncytial virus infection by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Costs and benefits of respiratory syncytial virus immunoglobulin to prevent hospitalization for lower respiratory tract illness in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Anaphylactic sensitization to aeroantigen during respiratory virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Allergic sensitization increases airway reactivity in guinea pigs with respiratory syncytial virus bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Development of allergen-specific T-cell memory in atopic and normal children.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

Family size, childhood infections and atopic diseases. The Aberdeen WHEASE Group

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980072-1

7 January 2021

10.1016/S1369-5274(99)80072-1

Identifiers

DOI

1 reference

28 July 2017

1 reference